ArticleInvestigational new drugs2024

Effect of early dose reduction of osimertinib on efficacy in the first-line treatment for EGFR-mutated non-small cell lung cancer.

Tomoki Hori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.